EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment

Yali Liu, Harry Cheuk-Hay Lau, Wing Yin Cheng, Jun Yu

Genomics, Proteomics & Bioinformatics · 01.02.2023 · 21 (1) · 84-96

DOI: 10.1016/j.gpb.2022.07.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genomics, Proteomics & Bioinformatics, online erschienen am 30.07.2022. Verfasst von Yali Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Disease and The Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of H…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colorectal Neoplasms, Microbiota. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Grants Council Theme-based Res Scheme Hong Kong, RGC Collaborative Research Fund, RGC-General Research Fund Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers and the leading cause of cancer-associated deaths. Epidemiological studies have shown that both genetic and environmental risk factors contribute to the development of CRC. Several metagenomic studies of CRC have identified gut dysbiosis as a fundamental risk factor in the evolution of colorectal malignancy. Although enormous efforts and substantial progresses have been made in understanding the relationship between human gut microbiome and CRC, the precise mechanisms involved remain elusive. Recent data have shown a direct causative role of the gut microbiome in DNA damage, inflammation, and drug resistance in CRC, suggesting that modulation of gut microbiome could act as a powerful tool in CRC prevention and therapy. Here, we provide an overview of the relationship between gut microbiome and CRC, and explore relevant mechanisms of colorectal tumorigenesis. We next highlight the potential of bacterial species as clinical biomarkers, as well as their roles in therapeutic response. Factors limiting the clinical translation of gut microbiome and strategies for resolving current challenges are further discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColorectal NeoplasmsMicrobiotaHumansBiomarkersCarcinogenesis

Stichwörter der Autor:innen

ChemotherapyColorectal cancerDiagnostic biomarkerGut microbiomeImmunotherapy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Institute of Digestive Disease and The Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese Universi…

Förderung

  • Research Grants Council Theme-based Res Scheme Hong Kong
  • RGC Collaborative Research Fund
  • RGC-General Research Fund Hong Kong

Zitieren

APA

Liu, Y., Lau, H. C., Cheng, W. Y., & Yu, J. (2023). Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment. Genomics, Proteomics & Bioinformatics, 21(1), 84-96. https://doi.org/10.1016/j.gpb.2022.07.002

Vancouver

Liu Y, Lau HC, Cheng WY, Yu J. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment. Genomics, Proteomics & Bioinformatics. 2023;21(1):84-96. doi:10.1016/j.gpb.2022.07.002

BibTeX
@article{Liu2023,
  author = {Liu, Yali and Lau, Harry Cheuk-Hay and Cheng, Wing Yin and Yu, Jun},
  title = {Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment},
  journal = {Genomics, Proteomics & Bioinformatics},
  year = {2023},
  volume = {21},
  number = {1},
  pages = {84--96},
  doi = {10.1016/j.gpb.2022.07.002}
}
Kostenlos starten →